$Selinexor‐based regimens for the treatment of myeloma refractory to chimeric antigen receptor T cell therapy$

Selinexor‐based regimens for the treatment of myeloma refractory to chimeric antigen receptor T cell therapy

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2020-05, Vol.189 (4), p.e126-e130
Hauptverfasser:	Chari, Ajai, Vogl, Dan T., Jagannath, Sundar, Jasielec, Jagoda, Unger, Thaddeus J., DeCastro, Andrew, Shah, Jatin, Kauffman, Michael, Shacham, Sharon, Jakubowiak, Andrzej
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged bortezomib carfilomib Cell therapy Cell- and Tissue-Based Therapy - methods chimeric antigen receptor T cell refractory Female Hematology Humans Hydrazines - pharmacology Hydrazines - therapeutic use Lymphocytes T Male Middle Aged multiple myeloma Multiple Myeloma - drug therapy Myeloma Receptors, Chimeric Antigen - therapeutic use selinexor Triazoles - pharmacology Triazoles - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!